Bicycle Therapeutics is a biopharma company targeting unmet medical needs. Discover why BCYC stock benefits from strong ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

4-dihydroxyphenylalanine (dopa): ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, and ethylene glycol monobutyl ether. The monoethyl ether had the greatest solvent power.

At the forefront of its pipeline is CRB-701, an antibody-drug conjugate (ADC) targeting Nectin-4 on cancer cells. This ...

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, especially ...

Background: Multiple sclerosis is a chronic inflammatory disease of the central nervous system with a pronounced neurodegenerative component. It has been suggested that novel treatment options are ...

Future Neurology. 2012;7(6):679-700. Isolated CN palsies are rare signs of MS. [143] Lesions within the brainstem may cause injury to the CN III, CN IV or CN VI nuclei or fascicles resulting in ...

NextCure (NXTC) reported pre-clinical data from LNCB74, a B7-H4-targeting antibody-drug conjugate, or ADC, being developed in partnership with ...